WG Critical Care

TENIPOSIDE

  1. Home
  2.  / 
  3. Q Code
  4.  / TENIPOSIDE – Q2017

Manufacturer:

WG Critical Care

Name:

TENIPOSIDE

Category:

Q Code

HCPCS:

Q2017

NDC(s):

44567-0507-01,

Primary Type:

Cancer

Route of Administration:

Intravenous

About:

TENIPOSIDE is a Cancer drug manufactured by WG Critical Care and administered via the Intravenous route of administration. The Q Code: Q2017 is aligned to the drug TENIPOSIDE.

Access Pricing and More By Registering